ForeFront Block Grants

University Technologies International

The initial funding in 2007 from AHFMR to University Technologies International (UTI) was $105,000. UTI's role was to administer allocation of funds to selected qualified pre-commercial technologies for activities such as technology evaluation, market research, intellectual property protection, marketing and proof-of-principle development.

UTI is recognized internationally for its expertise and success in protecting, marketing and commercializing technology and innovators.

"UTI is committed to moving research-based technologies to market at a faster and more effective pace – AHFMR recognizes the need for the pre-commercialization capital required to make this happen. By combining the commercialization expertise of UTI with the additional funding support of AHFMR, we will great higher pre-commercial value that will mean better returns for all Albertans," said Paul Cataford, UTI's President and CEO. For more information, visit: www.uti.ca.